Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?

Transplantation Proceedings

Volumn 36, Issue 7, 2004, Pages 2056-2057

  Lai, W J ^a   Chiang, Y J ^a   Chen, Y ^a   Chu, S H ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HYPERLIPIDEMIA; HYPERURICEMIA; HYPOKALEMIA; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT FAILURE;

CHRONIC DISEASE; CREATININE; CYCLOSPORINE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; SIROLIMUS; TACROLIMUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 7044262185     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.09.007     Document Type: Conference Paper

References (6)

1. R.E. Morris, J. Wu, R Shorthouse Transplant Proc 22 1990 1683
2. R.E. Morris, B.M. Meiser, J Wu Transplant Proc 23 1991 521
3. S.M. Stepkowski, H. Chen, P Daloze Transplantation 51 1991 22
4. B.D. Kahan Transplant Proc 30 1998 2185
5. J.C. Hong, B.D. Kahan Transplantation Proc 33 2001 1003
6. R.E. Morris, W. Cao, X Hung Transplant Proc 27 1995 43